血液透析滤过与儿童炎症减轻及骨形成增加相关:3H研究
该研究为HDF, Hearts and Heights (3H)前瞻性队列的事后分析,纳入144名儿童,其中103名(61名HD,42名HDF)完成12个月随访。结果显示,与常规血液透析相比,血液透析滤过患儿炎症标志物较低,骨形成/骨吸收比值升高,且FGF23/klotho比值较低。
要点
- HDF患儿炎症标志物(IL-6、TNF-α、hs-CRP)在基线和12个月均低于HD。
- 12个月时HDF组骨特异性碱性磷酸酶/TRAP5b比值升高,HD组不变。
- HD组FGF23/klotho比值在12个月时是HDF组的3.86倍。
核心结论
- 儿童HDF患者较HD患者炎症水平更低、骨形成增加且FGF23/klotho比值更低。
研究设计与样本
- HDF, Hearts and Heights (3H)前瞻性队列研究的事后分析,基线横断面纳入144名儿童,103名(61名HD,42名HDF)完成12个月随访。
主要发现
- HDF组IL-6、TNF-α和hs-CRP在基线和12个月均低于HD组(P < .001)。
- 12个月时HDF组骨特异性碱性磷酸酶/TRAP5b比值升高(P = .004),HD组不变(P = .44)。
- 校正分析中,HD组骨特异性碱性磷酸酶/TRAP5b比值比HDF组低2.66倍(95%CI,-3.91至-1.41;P < .0001)。
- FGF23在基线两组相当(P = .52),12个月时HD组升高(P < .0001),HDF组不变(P = .34)。
- 12个月时HD组FGF23/klotho比值是HDF组的3.86倍(95%CI,2.15-6.93;P < .0001)。
临床怎么用
- 对于儿童透析患者,HDF可能改善炎症状态和骨代谢标志物谱,但需长期研究确认对骨折风险和心血管健康的影响。
局限性
- 为事后分析,样本量有限,随访12个月,需长期研究确定骨标志物改善对骨折风险及心血管健康的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients on dialysis have a high burden of bone-related comorbidities, including fractures. We report a post hoc analysis of the prospective cohort study HDF, Hearts and Heights (3H) to determine the prevalence and risk factors for chronic kidney disease-related bone disease in children on hemodiafiltration (HDF) and conventional hemodialysis (HD). METHODS: The baseline cross-sectional analysis included 144 children, of which 103 (61 HD, 42 HDF) completed 12-month follow-up. Circulating biomarkers of bone formation and resorption, inflammatory markers, fibroblast growth factor-23, and klotho were measured. RESULTS: Inflammatory markers interleukin-6, tumor necrosis factor-α, and high-sensitivity C-reactive protein were lower in HDF than in HD cohorts at baseline and at 12 months (P < .001). Concentrations of bone formation (bone-specific alkaline phosphatase) and resorption (tartrate-resistant acid phosphatase 5b) markers were comparable between cohorts at baseline, but after 12-months the bone-specific alkaline phosphatase/tartrate-resistant acid phosphatase 5b ratio increased in HDF (P = .004) and was unchanged in HD (P = .44). On adjusted analysis, the bone-specific alkaline phosphatase/tartrate-resistant acid phosphatase 5b ratio was 2.66-fold lower (95% confidence interval, -3.91 to -1.41; P < .0001) in HD compared with HDF. Fibroblast growth factor-23 was comparable between groups at baseline (P = .52) but increased in HD (P < .0001) and remained unchanged in HDF (P = .34) at 12 months. Klotho levels were similar between groups and unchanged during follow-up. The fibroblast growth factor-23/klotho ratio was 3.86-fold higher (95% confidence interval, 2.15-6.93; P < .0001) after 12 months of HD compared with HDF. CONCLUSION: Children on HDF have an attenuated inflammatory profile, increased bone formation, and lower fibroblast growth factor-23/klotho ratios compared with those on HD. Long-term studies are required to determine the effects of an improved bone biomarker profile on fracture risk and cardiovascular health.
引用
- Fischer DC, Smith C, De Zan F, et al. Hemodiafiltration Is Associated With Reduced Inflammation and Increased Bone Formation Compared With Conventional Hemodialysis in Children: The HDF, Hearts and Heights (3H) Study. Kidney Int Rep. 2021. PMID: 34514197. doi:10.1016/j.ekir.2021.06.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。